Home Department: Bioengineering
Faculty Advisor: Joseph DeSimone
Talk Title: 3D-printed lattice micro-array patches (L-MAPs) for versatile and tunable transdermal delivery
Event: Controlled Release Society 2024
Dr. Neir Eshel (he/him/his) is a tenure-track Assistant Professor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. His clinical focus is the full-spectrum mental health care of sexual and gender minorities, with particular interest in depression, anxiety, and the complex effects of trauma in this population. He works in collaboration with other primary care and mental health providers at the new Stanford LGBTQ+ program.
Home Department: Materials Science & Engineering
Faculty Advisor: Sarah Heilshorn
Talk Title: Engineering lipid mobility to enhance stress relaxation in hyaluronic acid hydrogels
Event: 2023 Biomedical Engineering Society
Dr. Nazish Sayed is an Associate Professor in the Department of Surgery, Division of Vascular Surgery, and The Stanford Cardiovascular Institute. Dr. Sayed received his MD from the University of Mumbai, India, and a PhD in Biomedical Sciences from the University of Medicine and Dentistry of New Jersey (Rutgers New Jersey Medical School). He also holds a Master’s degree in Molecular Biology from Montclair State University.
Awarded in 2024
Home Department: Bioengineering
Faculty Advisors: Jennifer Cochran (Bioengineering) and Mark Pegram (Medicine – Oncology)
Dr. Nathanael Gray's Laboratory develops first-in-class chemical probes that are used to gain new biological insights into cellular processes that drive cancer and other diseases, and to pharmacologically validate potential clinically relevant targets. They take an integrative approach that combines medicinal chemistry, structural biology, biochemistry and molecular and cell biology to develop new therapeutic strategies. Their work has contributed to several approved and clinical stage drugs targeting BCR-ABL, Sphingosine-1-phosphate receptor (S1PR), EGFR, EML4-ALK and CDK7.
Dr. Nathan Reticker-Flynn is a Biomedical Engineer and tumor immunologist working at the interfaces of cancer metastasis, tumor evolution, adaptive immunity, and immuno-oncology. His work employs mouse models and systems biology and genetic engineering to investigate interactions between tumors and the immune system during cancer metastasis. He performed his PhD work in Biomedical Engineering with Dr. Sangeeta Bhatia at MIT where he studied glycobiology and ECM interactions during cancer metastasis and his postdoctoral studies with Dr.
